DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United Kingdom
  • /
  • Capital Goods
Published
19 Mar 25
Updated
01 May 25
Views
129
Not Invested
CohortCHRT
CHRT logo
Fair Value
UK£18.07
Share price01 May
UK£11.7834.8% undervalued intrinsic discount
Loading
1Y-13.00%
7D4.25%

Rising Global Defense Budgets Will Expand International Markets

AN
AnalystConsensusTarget
AnalystConsensusTarget

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
19 Mar 25
Updated
01 May 25
Views
129
Not Invested
Fair ValueUK£18.07
Share priceUK£11.78
34.8% undervalued intrinsic discount
Narrative
Updates6

Last Update 01 May 25

Fair value Increased 37%
Read more
6 viewsusers have viewed this narrative update

Key Takeaways

  • Global defense spending and digital modernization drive strong demand for Cohort's core secure communications and electronic warfare solutions, supporting robust order growth and margin expansion.
  • Increased R&D and successful acquisitions broaden market reach and capabilities, especially in naval and AI-driven defense technologies, fueling further revenue and earnings growth.
  • Heavy reliance on key contracts, government spending, and successful acquisitions, alongside operational inefficiencies and shifting geopolitical factors, creates ongoing risks to sustainable growth and margins.

Catalysts

About Cohort
    Provides a various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Africa, North and South America, and the Asia Pacific and Africa, and other European countries.
What are the underlying business or industry changes driving this perspective?
  • Cohort is experiencing robust forward demand due to a global surge in defense budgets and heightened geopolitical instability, especially across NATO, Europe, and Asia-Pacific, leading to a record order book that covers ~85% of next year's revenue and underpins strong future revenue growth.
  • Sustained government investment in digital transformation and electronic warfare is driving a pipeline of orders for Cohort's core areas-secure communications, cyber, and advanced data analytics-providing opportunities for higher-margin contract wins and supporting net margin expansion in coming years.
  • Meaningful increases in internal R&D investment (up 35% YoY) are fueling product innovation in priority markets like AI-driven counter-drone systems, electronic warfare, and secure naval communications, which should boost Cohort's addressable market and earnings potential as modernization and technology adoption accelerate globally.
  • Proven ability to execute and integrate value-accretive acquisitions, exemplified by EM Solutions and ITS, is expanding Cohort's presence in international defense markets and communications technology, unlocking cross-selling, operational synergies, and further top-line revenue growth.
  • The continued global prioritization of maritime security-especially protection of critical sea lanes and submarine detection-directly benefits Cohort's specialized naval solutions (SEA, ELAC, EM Solutions), which positions the company to win a growing share of new high-value, multi-year international defense contracts and improve revenue visibility.
Cohort Earnings and Revenue Growth

Cohort Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Cohort's revenue will grow by 7.9% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 7.1% today to 8.7% in 3 years time.
  • Analysts expect earnings to reach £29.4 million (and earnings per share of £0.69) by about September 2028, up from £19.2 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 42.7x on those 2028 earnings, up from 30.9x today. This future PE is greater than the current PE for the GB Aerospace & Defense industry at 24.6x.
  • Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.04%, as per the Simply Wall St company report.
Cohort Future Earnings Per Share Growth

Cohort Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • The company's net margin declined slightly this year (from 10.4% to 10.2%) and was negatively impacted by operational inefficiencies in Chess and low-margin contracts at SEA; persistent issues in project delivery, supplier relationships, or undertrained staff at critical subsidiaries like Chess could lead to ongoing profitability pressures and margin erosion, impacting net earnings.
  • There are significant dependencies on large contracts (such as the one-off Royal Navy Ancilia order), UK government spending, and the maritime sector; if UK defense budgets are reprioritized, cut, or major programs delayed or canceled due to political or fiscal shifts, this concentration exposes Cohort to revenue instability.
  • Rapidly evolving competitive dynamics in counter-drone, AI, and cyber domains-with rising numbers of specialist players and new entrants (e.g., Anduril's UK presence)-could erode Cohort's market share, increase pricing pressure, and affect both order intake and long-term revenue growth if Cohort fails to keep pace on innovation.
  • Ongoing and future performance improvements depend significantly on successful integration of recent and future acquisitions (e.g., EM Solutions, ITS); failures in integration, or difficulties managing geographically distant or culturally different businesses, may prevent realization of expected synergies and drag on group earnings and profitability.
  • Political volatility and shifts in international alliances-such as uncertainties around the AUKUS agreement, US policy reversals, and changes in NATO defense commitments-risk destabilizing anticipated demand growth for defense technologies and may result in unpredictable delays or reductions in Cohort's order book and future revenues.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of £18.067 for Cohort based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be £339.1 million, earnings will come to £29.4 million, and it would be trading on a PE ratio of 42.7x, assuming you use a discount rate of 8.0%.
  • Given the current share price of £13.06, the analyst price target of £18.07 is 27.7% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Cohort?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

CHRT logo
Cohort
45.2% undervalued intrinsic discount

Longer Defence Programmes And Autonomous Systems Will Support Stronger Future Earnings Resilience

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 15 Jul
Read Narrative
CHRT logo
Cohort
12.7% undervalued intrinsic discount

Defence Order Delays And Cash Strain Will Eventually Support Long Term Earnings Momentum

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Published 13 May
Read Narrative

Fair Value vs Share Price

UK£18.07
vs UK£11.7834.8% undervalued intrinsic discount
PastFuture0398m2014201720202023202520262028Revenue UK£397.7mEarnings UK£34.4m
13.8%
Revenue growth
8.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Cohort

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Flawless balance sheet and undervalued.

Market capUK£542.3m
PB2.9x
Estimated Growth6.7%
Dividend Yield1.5%
Full analysis

CEO & management

Andrew Thomis
CEO
3.3yrs
CEO Tenure

Provides various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Australia, North and South America, Asia Pacific, Africa, and other European countries.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide